-
Jan 3, 2022, 08:21
by
Bob Davis
Dr. Wiegand serves as Associate Professor of Emergency Medicine and the Director of Addiction Toxicology and the Toxicology/Addiction Consult Service at Strong Memorial Hospital and the University of Rochester Medical Center. He started treating addiction 20 years ago and has since worked to bridge the fields of addiction medicine and medical toxicology. His efforts to do so contributed to him winning ASAM’s Annual Award, which he said he is honored to receive.
Full story
-
Dec 21, 2021, 15:24
by
Bob Davis
On December 20th, the New York Society of Addiction Medicine (NYSAM) sent a letter to Governor Kathy Hochul urging her to sign A2030/S649. This legislation would remove prior authorization on all forms of medication for addiction treatment (MAT) within the state’s Medicaid program.
Full story
-
Dec 6, 2021, 16:31
by
Bob Davis
On December 2nd, ASAM sent a letter to the Food and Drug Administration (FDA) responding to their request for feedback in reevaluating the voluntary status of the Opioid Analgesics (OA) Risk Evaluation and Mitigation Strategy (REMS) program. Currently, FDA is considering extending the REMS program to become a mandatory course for all opioid prescribers.
Full story
-
Dec 6, 2021, 14:51
by
Bob Davis
“I'm honored and gratified that the work I've done has been impactful enough to get that kind of recognition,” said Dr. Mee-Lee, president of DML Training and Consulting. “It’s a real honor and privilege to have been chosen.”
Full story
-
Dec 6, 2021, 14:11
by
Bob Davis
Penny S. Mills, MBA, former Executive Vice President/CEO of the ASAM receives the 2021 James H. Tharp Award. This annual trust award is given to the individual that has contributed most toward the solution of the problem of alcoholism.
Full story
-
Dec 2, 2021, 09:21
by
Bob Davis
ASAM launches its first-ever massive open online course (MOOC) on addiction medicine, open to a global audience including the public, patients, and providers.
Full story
-
Dec 1, 2021, 14:57
by
Bob Davis
OHSAM sent a letter to members of the Senate Committee on Small Business and Economic Opportunity opposing SB 261. SB 261 would update the regulatory framework governing the state’s medical cannabis program.
Full story
-
Nov 19, 2021, 02:00
by
Bob Davis
Nation’s leading association of addiction medicine physicians and other clinicians commend inclusion of provisions that would improve equitable coverage and access to comprehensive addiction care, and reduce the shortages of, and strengthen, the addiction treatment workforce
Full story
-
Nov 17, 2021, 14:50
by
Jaida Montenegro
Conversation on the Future of Science Research of Addiction Medicine with Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH), and Maureen Boyle, PhD, Chief Quality and Science Officer at ASAM.
Full story
-
Nov 9, 2021, 02:00
by
Bob Davis
The new toolkit, authored by Manatt Health Strategies in collaboration with the American Society of Addiction Medicine and Well Being Trust, provides ways for ensuring consistent use of patient-centered addiction care across providers, payers, and patients
Full story
-
Nov 5, 2021, 02:00
by
Jaida Montenegro
On November 5th, ASAM sent a letter to Senators Chris Murphy and Bill Cassidy in response to their request for input on policies to improve mental health and substance use disorder care.
Full story
-
Nov 1, 2021, 02:00
by
Bob Davis
On July 1, 2020, Louis Baxter, Sr., MD, DABAM, DFASAM, watched with gratitude as a vision he helped cast became a reality. That day marked the inaugural graduation of fellows from Howard University Medical School’s new Addiction Medicine Fellowship Program. Dr. Baxter, the program’s co-founder and director, helped establish the program with the goal of providing addiction medicine services to underprivileged patients in the DC metropolitan area.
Full story
-
Nov 1, 2021, 02:00
by
Jaida Montenegro
On November 1st, the Michigan Society of Addiction Medicine (MISAM) sent a letter to the membership of the House Committee on Health Policy in support of SB 412. If enacted, SB 412 would remove prior authorization requirements on FDA-approved medications for opioid use disorder within the state’s Medicaid program.
Full story
-
Oct 28, 2021, 02:00
by
Jaida Montenegro
This statement highlights specific policy recommendations to improve both access to, and the quality of, methadone treatment for OUD by making it more patient-centered and integrated with other medical care.
Full story
-
Oct 15, 2021, 02:00
by
Jaida Montenegro
On October 13th, ASAM, along with members of the Coalition to Stop Opioid Overdose (CSOO) and members of the Mental Health Liaison Group (MHLG), sent a letter to Chairman Ron Wyden and Ranking Member Mike Crapo of the Senate Committee on Finance, encouraging full extension of federal mental health and substance use disorder parity protections to Medicare, all of Medicaid, and TRICARE.
Full story
-
Oct 4, 2021, 02:00
by
Jaida Montenegro
On October 4th, the Ohio Society of Addiction Medicine (OHSAM) sent a letter to Senator Terry Johnson of the Ohio General Assembly highlighting concerns with his recently introduced bill SB 216 or “Dylan’s Law.”
Full story
-
Sep 29, 2021, 02:00
by
Jaida Montenegro
The American Society of Addiction Medicine and the American Medical Association today released new recommendations as part of the AMA Substance Use and Pain Care Task Force to help end the nation’s drug-related overdose and death epidemic.
Full story
-
Sep 17, 2021, 02:00
by
Jaida Montenegro
On September 17th, the Northern New England Society of Addiction Medicine (NNESAM) sent a letter to Governor Janet Mills urging her to reinstate Executive Order 27, which expanded syringe services programs (SSPs) in Maine.
Full story
-
Sep 16, 2021, 02:00
by
Jaida Montenegro
On September 10th, the American Society of Addiction Medicine (ASAM) submitted a comment letter to the Centers for Medicare & Medicaid Services (CMS) outlining suggested improvements to the proposed Physician Payment Schedule for calendar year (CY) 2022.
Full story
-
Sep 13, 2021, 01:00
by
Jaida Montenegro
On September 10th, the American Society of Addiction Medicine (ASAM), along with dozens of partner organizations, sent a letter to Chair Patty Murray of the Senate Committee on Health, Education, Labor, and Pensions (HELP) urging for the inclusion of enhanced mental health and substance use disorder (SUD) parity enforcement within the Senate’s version of the budget reconciliation proposal.
Full story